“To Compare the Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin Among Dyslipidemic Diabetic Patients at a Tertiary Centre in Bihar ”. Journal of Pharmaceutical Negative Results, Feb. 2023, pp. 672-6, https://doi.org/10.47750/pnr.2023.14.03.087.